References
- Elphee E. Caring for patients with chronic lymphocytic leukemia. Clin J Oncol Nurs 2008;12:47.
- D’Arena G, Simeon V, D’Auria F, et al. Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander? Am J Blood Res 2013;3:52–57.
- Dores GM, Anderson WF, Curtis RE, et al. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 2007;139:809–819.
- Shanafelt T, Byrd J, Call T, et al. Initial management of newly diagnosed, early stage, chronic lymphocytic leukemia: an update for the internist. Ann Intern Med 2006;145:435–447.
- Levin TT, Li Y, Riskind J, et al. Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort. Gen Hosp Psychiatry 2007;29:251–256.
- Evans J, Ziebland S, Pettitt AR. Incurable, invisible and inconclusive: watchful waiting for chronic lymphocytic leukaemia and implications for doctor-patient communication. Eur J Cancer Care (Engl) 2012;21:67–77.
- Oscier D, Dearden C, Eren E, et al. British Committee for Standards in Haematology. Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. Br J Haematol 2012;159:541–564.
- NICE technology appraisal guidance 216. Bendamustine for the first line treatment of chronic lymphocytic leukaemia. Issued: February 2011. Available from: guidance.nice.org.uk/ta216
- Blankart CR, Koch T, Linder R, et al. Cost of illness and economic burden of chronic lymphocytic leukemia. Orphanet J Rare Dis 2013;8:32.
- Brooks, R. EuroQol: the current state of play. Health Policy 1996;37:53–72.
- Office for National Statistics. 2011. Available from: www.ons.gov.uk/ons/guide-method/census/2011/index.html
- Shingler, SL, Swinburn P, Lloyd A, et al. Elicitation of health state utilities in soft tissue sarcoma. Qual Life Res 2013;22: 1697–1706.
- Swinburn, P, Lloyd A, Nathan P, et al. Elicitation of health state utilities in metastatic renal cell carcinoma. Curr Med Res Opin 2010;26:1091–1096.
- Kind P, Dolan P, Gudex C, et al. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1996;316:736–741.
- National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. June 2008. Available from: www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf
- Measurement of health state utility values for economic models in clinical studies – good practices task force. Available from: www.ispor.org/TaskForces/Health-Utility-Values-In-Clinical-Studies-GRP.asp
- Lloyd A, Nafees B, Moore L, et al. Practical difficulties with conducting non-interventional research for NICE technology appraisals: a case study in a quality of life assessment of chronic lymphocytic leukaemia patients. Poster presented at British Society for Haematology, 50th Annual Scientific Meeting, Edinburgh, 2010.